Field of the Invention
The invention relates to a Zr-based bulk amorphous alloy, and more particularly to a bulk amorphous alloy Zr—Cu—Ni—Al—Ag—Y featuring high amorphous forming ability and antimicrobial properties, as well as methods of preparing and using the same.
Description of the Related Art
Featuring numerous excellent properties, amorphous alloys have been developing quickly in the past few decades and aroused more and more attention. Specifically, Zr-based amorphous alloy exhibits high amorphous forming ability and excellent overall performance, and thus is widely used.
However, conventional Zr-based alloy, for example, Zr—Ti—Cu—Ni—Be alloy, is poisonous; Zr—Ti—Cu—Ni—Al alloy and Zr—Nb—Cu—Ni—Al alloy have low amorphous forming ability. In addition, the amorphous alloys are formed under harsh conditions, thereby increasing the production cost.
In view of the above-described problems, it is one objective of the invention to provide a bulk amorphous alloy Zr—Cu—Ni—Al—Ag—Y that has high amorphous forming ability, manufacturability and antimicrobial properties, as well as methods of preparing and using the same. Through the introduction of the elements Ag and Y to a quaternary alloy Zr—Cu—Ni—Al and the strong interaction of the element Ag and the element Y, the atomic diffusion during the alloy solidification is impeded, and the precipitation of the crystalline phase is slowed down. As a result, the obtained alloy Zr—Cu—Ni—Al—Ag—Y has high amorphous forming ability, excellent antimicrobial properties, and good manufacturability, and can be repeatedly cast at low degree of vacuum.
To achieve the above objective, in accordance with one embodiment of the invention, there is provided a bulk amorphous alloy, comprising, based on atomic percentage amounts, between 41 and 63% of Zr, between 18 and 46% of Cu, between 1.5 and 12.5% of Ni, between 4 and 15% of Al, between 0.01 and 5% of Ag, and between 0.01 and 5% of Y.
In a class of this embodiment, the alloy comprises, based on atomic percentage amounts, between 49 and 55% of Zr, between 28 and 36% of Cu, between 4 and 10% of Ni, between 2 and 7% of Al, between 0.02 and 1.45% of Ag, and between 0.05 and 3% of Y.
In a class of this embodiment, the alloy has a biggest shape size greater than 20 mm, and the following characteristic thermodynamic parameters: glass transition temperature, between 405 and 420° C.; supercooled liquid region, ΔT=30-70° C.; initial melting temperature, 707-793° C.
In a class of this embodiment, the alloy has a compressed rupture strength of between 1.0 and 1.9 GPa.
In a class of this embodiment, the alloy has good antimicrobial properties and manufacturability, and after four times' casting, the resulting product remains a pure amorphous structure.
The invention also provides a method for preparing a bulk amorphous alloy. The method comprises: 1) employing technical pure Zr, Cu, Ni, Al, Ag and Y as materials; 2) allowing the materials to undergo arc melting or induction melting in the presence of argon to yield a master ingot; and 3) performing copper mold casting on the master ingot to yield the bulk amorphous alloy. The copper mold casting is performed with the following technical parameters: degree of vacuum, between 10−1 and 10−2 Pa; temperature, between 980 and 1400° C.; and cooling rate, between 10 and 102 K/s.
Advantages of the bulk amorphous alloy according to embodiments of the invention are summarized as follows.
1. On the basis of a quaternary alloy Zr—Cu—Ni—Al, the invention introduces the metal Ag and the rare earth element Y, whereby obtaining a novel bulk amorphous alloy Zr—Cu—Ni—Al—Ag—Y. Through the strong interaction between the element Ag and the element Y, the atomic diffusion during the alloy solidification is impeded, and the precipitation of the crystalline phase is slowed down. As a result, the obtained alloy Zr—Cu—Ni—Al—Ag—Y has high amorphous forming ability and the largest size of the amorphism is greater than 20 mm. In addition, the amorphous alloy has antimicrobial properties, and the bactericidal rate thereof against E. Coli is greater than or equal to 99.9%.
2. Due to the addition of the element Y and the interaction between the metals Y and Ag, the oxygen element of the melt resulting from the alloy melting is floated on the surface of the alloy melt, thereby purifying the alloy melt, so that, after repeated casting in low vacuum (the degree of vacuum is between 10−1 and 10−2 Pa), the amorphous alloy still exhibits high amorphous forming ability, which is beneficial to the mass production process and the application of the amorphous alloy.
3. The amorphous alloy Zr—Cu—Ni—Al—Ag—Y has excellent mechanical properties, for example, the compressed rupture strength thereof is 1.9 GPa.
4. The main elements of the amorphous alloy Zr—Cu—Ni—Al—Ag—Y comprising Zr, Cu, and Ni are technical pure materials, thereby reducing the production cost.
5. The Zr-based amorphous alloy can be used for preparing antimicrobial material in the field of consumer electronics, health care, kitchen wares, and transportation.
For further illustrating the invention, experiments detailing a bulk amorphous alloy Zr—Cu—Ni—Al—Ag—Y and methods of preparing and using the same are described below. It should be noted that the following examples are intended to describe and not to limit the invention.
Table 1 lists several bulk amorphous alloy samples as well as the components thereof.
The bactericidal rate of the bulk amorphous alloy samples is measured using a coating film method (refer to JIS Z 2801-2000), and the concentration of the used E. coli ATCC25922 solution is 4.2×105 cfu/mL.
The specific Zr-based amorphous alloy is Zr54.53Cu29.75Ag0.3Ni4.97Al9.95Y0.5 (at. %) (sample No. 2 in Table 1).
Technical pure metals Zr, Cu, Ni, Al, Ag, Y were selected as materials, and the element Zr employed zirconium sponge. The materials were mixed according to atomic percentage amounts, and allowed to undergo arc melting in the presence of argon, to yield a master ingot. To ensure the uniformity, the alloy ingot was melted reversely for at least four times. The master ingot was remelt and blown into a copper mold with a diameter of 20 mm using vacuum casting equipment. The operation temperature was 1000° C., and the degree of vacuum was 10−1 Pa.
X-ray diffraction showed that, the alloy was a single pure amorphous structure, as shown in
The bactericidal rate of the bulk amorphous alloy against E. Coli was greater than or equal to 99.9%.
As shown in
Different from Example 1, the specific Zr-based amorphous alloy is Zr52Cu34.9Ag0.1Ni5Al7.5Y0.5 (at. %) (sample No. 3 in Table 1).
X-ray diffraction showed that, the alloy was a single pure amorphous structure, as shown in
Different from Example 1, the specific Zr-based amorphous alloy is Zr55.03Cu29.75Ag0.1Ni4.97Al9.95Y0.2 (at. %) (sample No. 4 in Table 1).
X-ray diffraction showed that, the alloy was a single pure amorphous structure. The glass transition temperature Tg of the alloy was 420° C.; the supercooled liquid region ΔT thereof was 60° C.; the initial melting temperature Tm thereof was 730° C.; and the compressed rupture strength thereof was 1.9 GPa. Other properties were the same as that in Example 1.
Different from Example 1, the specific Zr-based amorphous alloy is Zr50.8Cu35.9Ag0.1Ni4Al9Gd0.2 (at. %) (sample No. 1 in Table 1).
X-ray diffraction showed that, the alloy was a single pure amorphous structure, as shown in
Different from Example 1, the specific Zr-based amorphous alloy is Zr51Cu30Ag3Ni5Al11.
When the alloy underwent the second casting at low vacuum, crystalline phase precipitated from the cast sample.
Different from Example 1, the specific Zr-based amorphous alloy is Zr52Cu35Ni5Al7.5Y0.5.
The amorphous forming ability of the alloy was less than 9 mm and no bactericidal effect detected.
While particular embodiments of the invention have been shown and described, it will be obvious to those skilled in the art that changes and modifications may be made without departing from the invention in its broader aspects, and therefore, the aim in the appended claims is to cover all such changes and modifications as fall within the true spirit and scope of the invention.
Number | Date | Country | Kind |
---|---|---|---|
2014 1 0078957 | Mar 2014 | CN | national |
This application is a continuation-in-part of International Patent Application No. PCT/CN2014/075458 with an international filing date of Apr. 16, 2014, designating the United States, now pending, and further claims priority benefits to Chinese Patent Application No. 201410078957.8 filed Mar. 5, 2014. The contents of all of the aforementioned applications, including any intervening amendments thereto, are incorporated herein by reference. Inquiries from the public to applicants or assignees concerning this document or the related applications should be directed to: Matthias Scholl P. C., Attn.: Dr. Matthias Scholl Esq., 245 First Street, 18th Floor, Cambridge, Mass. 02142.
Number | Name | Date | Kind |
---|---|---|---|
20110094633 | Gong | Apr 2011 | A1 |
20110308671 | Gong | Dec 2011 | A1 |
Number | Date | Country |
---|---|---|
102080196 | Jun 2011 | CN |
Entry |
---|
English Translation of CN 102080196. |
Number | Date | Country | |
---|---|---|---|
20150322555 A1 | Nov 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/CN2014/075458 | Apr 2014 | US |
Child | 14806678 | US |